Edition:
United Kingdom

People: Alpine Immune Sciences Inc (ALPN.OQ)

ALPN.OQ on NASDAQ Stock Exchange Global Market

4.22USD
16 Aug 2019
Change (% chg)

$0.43 (+11.35%)
Prev Close
$3.79
Open
$3.90
Day's High
$4.85
Day's Low
$3.90
Volume
12,201
Avg. Vol
2,420
52-wk High
$7.99
52-wk Low
$3.46

Gombotz, Wayne 

Dr. Wayne R. Gombotz Ph.D. is Chief Technology Officer of the company. Dr. Gombotz has more than 30 years' experience in the biotech and pharma industries and most recently served as the Chief Development Officer at Immune Design. As Chief Development Officer at Immune Design, Dr. Gombotz was responsible for advancing several immuno-oncology products from bench to pivotal clinical trials. Prior to Immune Design, He held senior roles at Omeros Corporation, Corixa Corporation, and Amgen (formerly Immunex), where he played a major role in the development and launch of ENBREL®, one of the top-selling drugs for psoriasis and multiple arthritis conditions. Dr. Gombotz currently serves as an Advisory Board Member for the University of Washington's Department of Bioengineering and was a recent recipient of the University of Washington College of Engineering's 2019 Diamond Award for Distinguished Achievement in Industry. Dr. Gombotz holds a PhD and MS in Bioengineering from the University of Washington and a BA in biology from Colby College.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --